How do I calculate peptide concentration after reconstitution?

Divide the vial's labelled mass by the volume of diluent added. A 5 mg vial in 2 mL gives 2.5 mg/mL. Record the exact volume delivered, since syringe tolerance introduces several percent of error.

Should I correct for net peptide content?

Yes, whenever results will be compared to published molar potency values. Labelled strength is usually gross mass, and peptide content for TFA-salted material is commonly 70-90% of that figure.

How many freeze-thaw cycles can a peptide solution take?

It is sequence-dependent, but measurable loss often appears after three or four cycles. Aliquoting into single use volumes before the first freeze avoids the issue.

Handling · 6 min read

Concentration calculations for reconstituted peptides

Working through mass-to-volume arithmetic, molar concentration from labelled strength, and the peptide-content correction that most calculations quietly omit.

Mass per volume is the easy part

A 5 mg vial reconstituted with 2 mL of diluent yields 2.5 mg/mL. Reconstituted with 5 mL it yields 1 mg/mL. The arithmetic is trivial; what matters is recording the exact volume added, because a nominal 2 mL delivered from a syringe is frequently 1.9 or 2.1 mL, and that is a 5% error propagating through every downstream dilution.

For work where concentration accuracy matters, reconstitute gravimetrically. Weigh the vial before and after adding diluent and calculate volume from mass, taking density as 1.0 g/mL for aqueous diluents. This removes syringe tolerance from the chain entirely.

Converting to molar concentration

Molar concentration requires the molecular weight, which appears on the certificate of analysis and in the product monograph. Molarity equals mass concentration divided by molecular weight: a 1 mg/mL solution of a peptide with a molecular weight of 1419 g/mol is approximately 705 µM.

Use the free-base molecular weight rather than the salt-form weight unless the certificate states otherwise, and be explicit in your notes about which you used. Papers that report activity in molar terms are assuming free-base mass, and mixing conventions introduces a silent offset of several percent.

The peptide content correction

Labelled strength is usually gross vial mass. The actual peptide fraction — net peptide content — is typically 70% to 90% for TFA-salted material, with the balance made up of counter-ions and residual water. A vial labelled 5 mg with 80% peptide content contains 4 mg of peptide.

For qualitative screening this rarely matters. For any experiment where the reported concentration will be compared with published EC50 values, apply the correction and state it in your methods. Two laboratories reporting different potencies for the same compound are, more often than not, reporting different content conventions.

Aliquoting to avoid freeze-thaw

Once the working concentration is established, split the solution into single use aliquots before freezing. Each freeze-thaw cycle concentrates solutes at the ice boundary and exposes the peptide to transient pH shifts; three or four cycles are enough to produce measurable loss in sensitive sequences.

Label every aliquot with compound, lot, concentration, diluent and date. A tube marked only with a compound name is unusable data six months later.

Frequently asked questions

How do I calculate peptide concentration after reconstitution?: Divide the vial's labelled mass by the volume of diluent added. A 5 mg vial in 2 mL gives 2.5 mg/mL. Record the exact volume delivered, since syringe tolerance introduces several percent of error.
Should I correct for net peptide content?: Yes, whenever results will be compared to published molar potency values. Labelled strength is usually gross mass, and peptide content for TFA-salted material is commonly 70-90% of that figure.
How many freeze-thaw cycles can a peptide solution take?: It is sequence-dependent, but measurable loss often appears after three or four cycles. Aliquoting into single use volumes before the first freeze avoids the issue.